NewAmsterdam Pharma (NAMSW) Institutional Ownership $9.58 +0.76 (+8.62%) As of 06/20/2025 04:00 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisChartCompetitorsFinancialsOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for NewAmsterdam Pharma (NASDAQ:NAMSW)Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$660.53KNumber ofInstitutional Sellers(last 12 months)1TotalInstitutional Outflows(last 12 months)$34.82K Get NAMSW Insider Trade Alerts Want to know when executives and insiders are buying or selling NewAmsterdam Pharma stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data NAMSW Institutional Buying and Selling by Quarter NewAmsterdam Pharma Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/14/2025 Affinity Asset Advisors LLC241,957$2.18M0.2%+1.7%0.000% 5/12/2025 Wolverine Asset Management LLC8,884$80K0.0%-30.0%0.000% 2/13/2025 Affinity Asset Advisors LLC237,935$3.33M0.4%+11.7%0.000% 2/3/2025 Wolverine Asset Management LLC12,693$181K0.0%N/A0.000% 7/23/2024 TFC Financial Management Inc.10,000$87K0.0%N/A0.000% 5/15/2024 Affinity Asset Advisors LLC202,599$2.24M0.3%+47.9%0.000% 2/15/2024 Clear Street LLC8,993$28K0.0%-33.2%0.000% 2/14/2024 ADAR1 Capital Management LLC82,857$259K0.1%N/A0.000% 11/15/2023 Affinity Asset Advisors LLC137,000$260K0.1%+270.3%0.000% 8/7/2023 Wolverine Asset Management LLC12,448$26K0.0%N/A0.000% 5/15/2023 Affinity Asset Advisors LLC37,000$68K0.0%N/A0.000% 5/12/2023 Clear Street LLC17,619$32K0.0%N/A0.000% 5/11/2023 Highbridge Capital Management LLC733,327$1.36M0.0%+4.0%0.000% 5/10/2023Exos TFP Holdings LLC93,932$173K0.0%-31.6%0.000% 2/14/2023 RA Capital Management L.P.333,333$289K0.0%N/A0.000% 2/14/2023 EcoR1 Capital LLC66,665$727K0.0%N/A0.000% 2/10/2023Exos TFP Holdings LLC137,317$119K0.0%N/A0.000% 2/3/2023 Frazier Life Sciences Management L.P.500,333$434K0.0%N/A0.000% (Data available from 1/1/2016 forward) NAMSW Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of NAMSW shares? During the previous two years, the following institutional investors and hedge funds held shares of NewAmsterdam Pharma shares: Affinity Asset Advisors LLC ($2.18M), ADAR1 Capital Management LLC ($259K), TFC Financial Management Inc. ($87K), and Wolverine Asset Management LLC ($80K), Clear Street LLC ($28K).Learn more on NewAmsterdam Pharma's institutional investors. Which institutional investors have been buying NewAmsterdam Pharma's stock? The following institutional investors have purchased NewAmsterdam Pharma's stock in the last 24 months: Affinity Asset Advisors LLC ($194.58K), ADAR1 Capital Management LLC ($82.86K), Wolverine Asset Management LLC ($25.14K), and TFC Financial Management Inc. ($10K). How much institutional buying is happening at NewAmsterdam Pharma? Institutional investors have bought a total of 51,676 shares in the last 24 months. This purchase volume represents approximately $660.53K in transactions. Which of NewAmsterdam Pharma's major shareholders have been selling company stock? The following institutional investors have sold NewAmsterdam Pharma stock in the last 24 months: Wolverine Asset Management LLC ($3.81K). How much institutional selling is happening at NewAmsterdam Pharma? Institutional investors have sold a total of 3,809 shares in the last 24 months. This volume of shares sold represents approximately $34.82K in transactions. Related Companies Nutriband Major Shareholders This page (NASDAQ:NAMSW) was last updated on 6/22/2025 by MarketBeat.com Staff From Our Partners3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredWhen This Happens, You Don’t Wait. You Act.This same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored379 passengers walked away from thisForget OpenAI, ChatGPT, and the $2 trillion chip race… The real story is buried inside a new U.S. patent. E...True Market Insiders | SponsoredA grave, grave error.It seems like the world is on fire. Trump’s tariffs are crippling economies worldwide. Canada’s been cri...Porter & Company | SponsoredMost Bitcoin holders have no idea this existsHere’s what 99% of Bitcoin holders don’t know: There’s a way to amplify your Bitcoin gains without buying m...Brownstone Research | SponsoredTop Picks for Trump’s Pro-Crypto AmericaMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NewAmsterdam Pharma Please log in to your account or sign up in order to add this asset to your watchlist. Share NewAmsterdam Pharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
